Summary of the research/invention I work on prostate cancer research. Prostate cancer patients are often treated with androgen deprivation hormone therapies, but most eventually develop resistance to these treatments and progress poorly. In my research, I have generated cellular models that mimic the different stages in patients’ progression as they respond to different treatments. Using […]
Summary of the research/invention: The research team patented a series of potent inhibitors of NLRP3 inflammasome formation, the dysregulation of which is associated with several inflammatory disorders with high unmet medical demand, such as Alzheimer’s disease and lung cancer. Novel chemical synthesis conditions have been developed that allow the automated generation of a large number […]
Today, 26 April, is World Intellectual Property Day. This year is dedicated to intellectual property and youth: innovating for a better future. At CEFI we want to give a voice to young researchers in the biopharmaceutical sector. We are therefore presenting three projects involving three young researchers: Santiago Cañellas Román, Researcher at Janssen Cilag, Iris […]
Issue 80 of the journal Cuadernos, with highly topical content for the pharmaceutical sector, is available for purchase and download.
We at the CEFI Foundation are very proud to celebrate our 40th Anniversary this year. CEFI has been working in defence of innovation and intellectual property for 40 years, especially in the biomedical field. Thanks to the collaboration of leading experts, authorities and thousands of supporters, we are celebrating four decades of debate and analysis […]
Issue 79 of the journal Cuadernos, with highly topical content for the pharmaceutical sector, is available for purchase and download. Don’t miss out on issue 94 of the Comunicaciones journal!!
This paper analyses the promotion of medicines for human use that have already received marketing authorization, when the advertising is made before the resolution on pricing and inclusion in the Spanish National Health Service. This is an issue addressed by the recent Judgment of the High Court of Justice of the Basque Country (Administrative Chamber) […]
The promotion of medicines for human use that have already receive marketing authorization, before the resolution on pricing and the inclusión in the Nacional Health System. Angel García Vidal and Irene Fernández Puyol Health Data 29 Playbook as a gvernance framework fot he sharing and researchwith healthcaredata. Ricard Martínez Martínez, Gabriel López Serrano, Alejandro Padín […]
CEFI is organising a seminar on observational studies of medicinal products and patient support programmes, which is set to take place on 15 October. As of 2 January 2021, observational studies of medicinal products for human use (‘OSM’) are to be regulated in Spain by Royal Decree 957/2020, which repeals the previously applicable Order SAS/3470/2009. […]
Available for download. The promotion of medicines for human use that have already receive marketing authorization, before the resolution on pricing and the inclusión in the Nacional Health System. Angel García Vidal and Irene Fernández Puyol Health Data 29 Playbook as a gvernance framework fot he sharing and researchwith healthcaredata. Ricard Martínez Martínez, Gabriel López […]
Considerations on the pricing system for medicinal products. Lourdes Fraguas Gadea Abuse of dominant position consisting on predatory prices. Spanish Competition Authority Astrazeneca inhalers Decision. Alfonso Gutiérrez Hernández and Alberto Pérez Hernández Public supply of medicines. Doctrine generated by the Spanish Review Commissions on Public Procurement as of the entry into force of the Spanish […]
Three of the most recognized experts on IP farma in Spain Ángel García Vidal, profesor de Derecho Mercantil de la Universidad de Santiago de Compostela y Consejero Académico de Gómez Acebo y Pombo, Kiko Carrión García de Parada, Abogado socio de Eversheds Sutherland and Miquel Montañá-Mora, Abogado Socio de Ciiford Chance discuss about IP protection […]
